Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02259556
Brief Title: CD30-directed Chimeric Antigen Receptor T (CART30) Therapy in Relapsed and Refractory CD30 Positive Lymphomas (CART30)

First Submitted : October 5, 2014
First Submitted that Met QC Criteria : October 7, 2014
First Posted : October 8, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : January 26, 2016
Last Update Posted : January 28, 2016 (Estimate)